Gene: ERP29
Official Full Name: endoplasmic reticulum protein 29provided by HGNC
Gene Summary: This gene encodes a protein which localizes to the lumen of the endoplasmic reticulum (ER). It is a member of the protein disulfide isomerase (PDI) protein family but lacks an active thioredoxin motif, suggesting that this protein does not function as a disulfide isomerase. The canonical protein dimerizes and is thought to play a role in the processing of secretory proteins within the ER. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04355 | ERP29 Knockout cell line (HeLa) | Human | ERP29 | 1:3~1:6 | Negative | Online Inquiry |
KO04356 | ERP29 Knockout cell line (HCT 116) | Human | ERP29 | 1:2~1:4 | Negative | Online Inquiry |
KO04357 | ERP29 Knockout cell line (HEK293) | Human | ERP29 | 1:3~1:6 | Negative | Online Inquiry |
KO04358 | ERP29 Knockout cell line (A549) | Human | ERP29 | 1:3~1:4 | Negative | Online Inquiry |
ERP29 Gene Knockout Cell Lines are specialized cellular models that have been engineered to lack the expression of the ERP29 gene, a critical component involved in protein folding and quality control within the endoplasmic reticulum. By utilizing CRISPR-Cas9 technology, these cell lines provide researchers with a powerful tool to dissect the functional roles and pathways affected by ERP29 loss. This enables the exploration of various physiological and pathological processes, including cellular stress responses, neurodegenerative diseases, and cancer.
The key functions of ERP29 include its involvement in the regulation of protein maturation and secretion, which are essential for maintaining cellular homeostasis. By systematically studying these knockout cell lines, researchers can directly observe alterations in cell behavior, such as changes in protein trafficking and secretion rates. Additionally, these models facilitate the investigation of compensatory mechanisms activated in response to ERP29 deficiency, shedding light on cellular resilience and adaptation.
Scientifically, ERP29 Gene Knockout Cell Lines hold significant importance in both basic and applied research settings. In the realm of pharmaceutical development, these models can assist in evaluating the efficacy and safety of novel therapeutics targeting protein dissolution pathways. Moreover, they can provide insights into the mechanisms underlying diseases characterized by protein misfolding, thereby paving the way for potential therapeutic interventions.
What sets ERP29 Gene Knockout Cell Lines apart from alternative models is their precision and specificity; traditional methods often resort to pharmacological inhibitors or unreliable silencing techniques. Our cell lines offer a consistent and reproducible system that is invaluable in generating robust experimental data, leading to more reliable conclusions.
For researchers and clinicians, the ability to investigate the functional consequences of gene knockouts in a controlled environment represents an unparalleled opportunity to advance their work. Our commitment to providing high-quality biological products, backed by extensive expertise in genetic manipulation and cell line development, ensures that you are equipped with the best tools for your discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.